| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |